No Data
No Data
Mizuho Securities Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating
Earnings Call: Syndax Pharmaceuticals Outlines Q3 2024 Progress
Scotiabank Maintains Syndax Pharmaceuticals(SNDX.US) With Hold Rating, Maintains Target Price $23
TD Cowen Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating
Scotiabank Remains a Hold on Syndax Pharmaceuticals (SNDX)
A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $33 to $47
No Data
No Data